Meristem Family Wealth’s Gilead Sciences GILD Stock Holding History

Meristem Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$261K	Sell	4,387 -3,563	-45%	-$228K	0.03%	284
2021 Q4	$577K	Buy	7,950 +102	+1%	+$7.03K	0.05%	206
2021 Q3	$548K	Buy	+7,848	New	+$551K	0.05%	214
2016 Q2	–	Sell	-2,458	Closed	-$226K	–	107
2016 Q1	$226K	Buy	2,458 +209	+9%	+$18.8K	0.1%	103
2015 Q4	$228K	Buy	+2,249	New	+$234K	0.09%	102
2015 Q3	–	Sell	-1,949	Closed	-$228K	–	76
2015 Q2	$228K	Buy	+1,949	New	+$213K	0.1%	98
2014 Q4	–	Sell	-3,140	Closed	-$334K	–	117
2014 Q3	$334K	Hold	3,140	–	–	0.14%	74
2014 Q2	$260K	Buy	+3,140	New	+$244K	0.11%	91

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meristem Family Wealth's GILD Position: Q1 2022 in Review

Meristem Family Wealth reduced its Gilead Sciences (GILD) stake by 45% in Q1 2022, selling an estimated $228K and leaving 4,387 shares worth $261K. The position accounts for 0.03% of the portfolio, ranked #284.

Meristem Family Wealth first reported a position in GILD in Q2 2014 and has held it in 8 quarters since. The position peaked at $577K in Q4 2021. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Meristem Family Wealth held 4,387 shares of Gilead Sciences worth $261K as of Q1 2022.
Meristem Family Wealth sold 3,563 Gilead Sciences shares in Q1 2022, an estimated $228K.
Gilead Sciences made up 0.03% of Meristem Family Wealth's portfolio in Q1 2022, its #284 holding.
Meristem Family Wealth first reported a position in Gilead Sciences in Q2 2014 and has held it in 8 quarters since.
Meristem Family Wealth's Gilead Sciences position peaked at $577K in Q4 2021.
1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.